Award
NIH Reporter #5R01CA281285-03
Optimizing immunoradiotherapy for HNSCC
Recipient
Not specified
Award Amount
$664,000.00
Ceiling
$664,000.00
Awarded
August 15, 2025
Identifier
5R01CA281285-03
Award for research on optimizing immunoradiotherapy for head and neck squamous cell carcinoma, involving animal models and clinical trials, with a focus on lymph nodes' role in immunotherapy response.
Description
The project focuses on cancer immunotherapy, specifically head and neck squamous cell carcinoma (HNSCC). The research involves animal models and clinical trials. The project aims to understand the role of lymph nodes in immunotherapy response and optimize treatment strategies. The project duration is from September 2023 to August 2028.